Bone remodeling during fracture repair: The cellular picture
- PMID: 18692584
- DOI: 10.1016/j.semcdb.2008.07.004
Bone remodeling during fracture repair: The cellular picture
Abstract
Fracture healing is a complex event that involves the coordination of a variety of different processes. Repair is typically characterized by four overlapping stages: the initial inflammatory response, soft callus formation, hard callus formation, initial bony union and bone remodeling. However, repair can also be seen to represent a juxtaposition of two distinct forces: anabolism or tissue formation, and catabolism or remodeling. These anabolic/catabolic concepts are useful for understanding bone repair without giving the false impression of temporally distinct stages that operate independently. They are also relevant when considering intervention. In normal bone development, bone remodeling conventionally refers to the removal of calcified bone tissue by osteoclasts. However, in the context of bone repair there are two phases of tissue catabolism: the removal of the initial cartilaginous soft callus, followed by the eventual remodeling of the bony hard callus. In this review, we have attempted to examine catabolism/remodeling in fractures in a systematic fashion. The first section briefly summarizes the traditional four-stage view of fracture repair in a physiological manner. The second section highlights some of the limitations of using a temporal rather than process-driven model and summarizes the anabolic/catabolic paradigm of fracture repair. The third section examines the cellular participants in soft callus remodeling and in particular the role of the osteoclast in endochondral ossification. Finally, the fourth section examines the effects of delaying osteoclast-dependent hard callus remodeling and also poses questions regarding the crosstalk between anabolism and catabolism in the latter stages of fracture repair.
Similar articles
-
Bolus or weekly zoledronic acid administration does not delay endochondral fracture repair but weekly dosing enhances delays in hard callus remodeling.Bone. 2008 Oct;43(4):653-62. doi: 10.1016/j.bone.2008.05.019. Epub 2008 Jun 3. Bone. 2008. PMID: 18582604
-
Zoledronic acid suppresses callus remodeling but enhances callus strength in an osteoporotic rat model of fracture healing.Bone. 2015 Dec;81:702-711. doi: 10.1016/j.bone.2015.09.018. Epub 2015 Oct 3. Bone. 2015. PMID: 26434668
-
Matrix metalloproteinase-driven endochondral fracture union proceeds independently of osteoclast activity.J Bone Miner Res. 2013 Jul;28(7):1550-60. doi: 10.1002/jbmr.1889. J Bone Miner Res. 2013. PMID: 23408642
-
[Bone fracture and the healing mechanisms. The effects of anti-resorptive agents on fracture healing].Clin Calcium. 2009 May;19(5):673-9. Clin Calcium. 2009. PMID: 19398835 Review. Japanese.
-
[Bone fracture and the healing mechanisms. Histological aspect of fracture healing. Primary and secondary healing].Clin Calcium. 2009 May;19(5):627-33. Clin Calcium. 2009. PMID: 19398828 Review. Japanese.
Cited by
-
Arginine Availability in Reamed Intramedullary Aspirate as Predictor of Outcome in Nonunion Healing.Biomedicines. 2022 Oct 3;10(10):2474. doi: 10.3390/biomedicines10102474. Biomedicines. 2022. PMID: 36289736 Free PMC article.
-
The Effect of Space Travel on Bone Metabolism: Considerations on Today's Major Challenges and Advances in Pharmacology.Int J Mol Sci. 2021 Apr 27;22(9):4585. doi: 10.3390/ijms22094585. Int J Mol Sci. 2021. PMID: 33925533 Free PMC article. Review.
-
Real-Time Imaging of CCL5-Induced Migration of Periosteal Skeletal Stem Cells in Mice.J Vis Exp. 2020 Sep 16;(163):10.3791/61162. doi: 10.3791/61162. J Vis Exp. 2020. PMID: 33016934 Free PMC article.
-
The emerging role of tranexamic acid and its principal target, plasminogen, in skeletal health.Acta Pharm Sin B. 2024 Jul;14(7):2869-2884. doi: 10.1016/j.apsb.2024.03.033. Epub 2024 Mar 30. Acta Pharm Sin B. 2024. PMID: 39027253 Free PMC article. Review.
-
Co‑delivery and controlled release of stromal cell‑derived factor‑1α chemically conjugated on collagen scaffolds enhances bone morphogenetic protein‑2‑driven osteogenesis in rats.Mol Med Rep. 2016 Jul;14(1):737-45. doi: 10.3892/mmr.2016.5339. Epub 2016 May 24. Mol Med Rep. 2016. PMID: 27220358 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical